(Q38067507)

28 August 2017

1 reference

title

Combined use of nonculture-based lab techniques in the diagnosis and management of critically ill patients with invasive fungal infections (English)

1 reference

invasive fungal infections

28 August 2017

main subject

1 reference

Javier Pemán

1

1 reference

28 August 2017

Rafael Zaragoza

series ordinal

2

1 reference

28 August 2017

publication date

1 November 2012

1 reference

Expert Review of Anti-infective Therapy

28 August 2017

published in

1 reference

28 August 2017

volume

10

1 reference

28 August 2017

issue

11

1 reference

28 August 2017

page(s)

1321-1330

1 reference

The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Invasive mycoses: diagnostic challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Current diagnostic approaches to invasive candidiasis in critical care settings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Laboratory diagnosis of invasive aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

PCR-based diagnosis of human fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Correlation of clinical outcomes with β-glucan levels in patients with invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: influence on mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Diagnosis of invasive candidiasis by enzyme-linked immunosorbent assay using the N-terminal fragment of Candida albicans hyphal wall protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Evaluation of a novel enzyme-linked immunosorbent assay to detect immunoglobulin G antibody to enolase for serodiagnosis of invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Immunoglobulin G responses to a panel of Candida albicans antigens as accurate and early markers for the presence of systemic candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Preemptive antifungal therapy: still a way to go.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

PCR diagnosis of invasive candidiasis: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Multiplex PCR allows rapid and accurate diagnosis of bloodstream infections in newborns and children with suspected sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Evaluation of commercial universal rRNA gene PCR plus sequencing tests for identification of bacteria and fungi associated with infectious endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

False-positive Aspergillus antigenemia due to blood product conditioning fluids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Galactomannan detection in computerized tomography‐based broncho‐alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Aspergillus PCR: one step closer to standardization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

Galactomannan in Bronchoalveolar Lavage Fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.128

21 January 2018

Identifiers

DOI

10.1586/ERI.12.128

1 reference

28 August 2017

1 reference